Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VET3-TGI |
| Trade Name | |
| Synonyms | VET3TGI|VET3 TGI |
| Drug Descriptions |
VET3-TGI is an oncolytic vaccinia virus engineered to express CXCR3, IL-12 and an anti-TGFB1 mini-monomer, which may increase antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Pembrolizumab + VET3-TGI | Pembrolizumab VET3-TGI | 0 | 1 |
| VET3-TGI | VET3-TGI | 0 | 1 |